Shenouda Maged bought RLMD
December 15, 2025 · Form 4 insider transaction
Shenouda Maged bought 11,665 shares of Relmada Therapeutics, Inc. at $4.12 per share, a transaction worth $48.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,665
Price
$4.12
Total value
$48.1K
InsiderShenouda Maged
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 15, 2025
Filing dateDecember 16, 2025
Shares owned after800,000
OwnershipDirect
10b5-1 planNo
AmendedNo